Monument Therapeutics has received £500,000 grant funding from Innovate UK for the development of a schizophrenia treatment.
FundraisingHCML acquires healthcare rm
Latest Deals
CN Bio has raised $21 million in Series B funding.
FundraisingMarstead Living has secured mortgage finance from Federated Hermes Private Credit to buy an 18-acre site in Mill Hill, north London.
Project financing